Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nemat Khan

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Inflammopharmacology|November 16, 2013
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsNemat Khan, Maree T Smith
Molecules (Basel, Switzerland)|June 13, 2015
Neurotrophins and Neuropathic Pain: Role in PathobiologyNemat Khan, Maree T Smith
Frontiers in Molecular Neuroscience|December 5, 2017
Attenuation of the Infiltration of Angiotensin II Expressing CD3<sup>+</sup> T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia - A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT<sub>2</sub>) Receptor AntagonistNemat Khan, Arjun Muralidharan, Maree T Smith
Pharmacology, Biochemistry, and Behavior|September 17, 2014
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methodsNemat Khan, Trent M Woodruff, Maree T Smith
Trends in Pharmacological Sciences|March 26, 2026
April 2026 issue first authorsNemat Khan, Jeong-Yeon Min, Yutong Li, et al.
Pharmacology Research & Perspectives|July 15, 2015
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cordNemat Khan, Richard Gordon, Trent M Woodruff, et al.
Trends in Pharmacological Sciences|March 12, 2026
Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunitiesNemat Khan, Zikra M Zakriya, Pamela McCombe, et al.
Clinical and Experimental Pharmacology & Physiology|June 17, 2020
Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's diseaseStephen R Edwards, Nemat Khan, Elizabeth J Coulson, et al.
Frontiers in Pharmacology|March 2, 2026
Resveratrol reduces muscle atrophy and stress pathway activation in a combined disuse-hypoxia-mouse modelAziz Ahmad Khan, Sajid Khan Sadozai, Fawad Ali, et al.
Inflammopharmacology|October 2, 2017
Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic painNemat Khan, Andy Kuo, David A Brockman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Inflammopharmacology|November 16, 2013
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsNemat Khan, Maree T Smith
Molecules (Basel, Switzerland)|June 13, 2015
Neurotrophins and Neuropathic Pain: Role in PathobiologyNemat Khan, Maree T Smith
Frontiers in Molecular Neuroscience|December 5, 2017
Attenuation of the Infiltration of Angiotensin II Expressing CD3<sup>+</sup> T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia - A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT<sub>2</sub>) Receptor AntagonistNemat Khan, Arjun Muralidharan, Maree T Smith
Pharmacology, Biochemistry, and Behavior|September 17, 2014
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methodsNemat Khan, Trent M Woodruff, Maree T Smith
Trends in Pharmacological Sciences|March 26, 2026
April 2026 issue first authorsNemat Khan, Jeong-Yeon Min, Yutong Li, et al.
Pharmacology Research & Perspectives|July 15, 2015
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cordNemat Khan, Richard Gordon, Trent M Woodruff, et al.
Trends in Pharmacological Sciences|March 12, 2026
Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunitiesNemat Khan, Zikra M Zakriya, Pamela McCombe, et al.
Clinical and Experimental Pharmacology & Physiology|June 17, 2020
Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's diseaseStephen R Edwards, Nemat Khan, Elizabeth J Coulson, et al.
Frontiers in Pharmacology|March 2, 2026
Resveratrol reduces muscle atrophy and stress pathway activation in a combined disuse-hypoxia-mouse modelAziz Ahmad Khan, Sajid Khan Sadozai, Fawad Ali, et al.
Inflammopharmacology|October 2, 2017
Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic painNemat Khan, Andy Kuo, David A Brockman, et al.
Pageof 3